Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Pembrolizumab for locally advanced and recurrent/metastatic cutaneous squamous cell carcinoma (KEYNOTE-629 study): an open-label, nonrandomized, multicenter, phase II trial
Brett G.M. Hughes, Eva Muñoz‐Couselo, Laurent Mortier, Aase Bratland, Ralf Gutzmer, Osama Roshdy and 11 more
- Rank
- 37 of 3,031
- Percentile
- top 1.3%
- Where
- Annals of Oncology, 2021
- Citations
- 208
From the 2021 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.